L-LYSINE AESCINATE®

The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.

In case of any discrepancies, please contact us at tel. +380 44 490 75 22

Solution for injection 5 ml №10.

The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.

In case of any discrepancies, please contact us at tel. +380 44 490 75 22

  • As part of complex treatment of post-traumatic, intra- and postoperative oedemas of any localization, i.e. severe cerebral and spinal oedemas, including those with intracranial hemorrhages, increased intracranial pressure and dropsical swelling; liquor-venous disturbances in patients with chronic ischemia of the brain and vegetative-vascular dystonia; soft tissue oedemas involving musculoskeletal system accompanied with local blood circulation disorders and pain syndrome; oedematous and pain syndromes in the spine, body, and extremities; severe venous circulation disorders of the low extremities in patients with acute thrombophlebitis accompanied with swelling inflammation syndrome.
  • 1 ml of solution contains 1 mg of L-lysine aescinat®, equivalent to 100% substance.

Buy from partners

From undefined uah

Order

Check at pharmacy

Order

Order

From undefined uah

Order
or order from partners

Legal Agreement for Information Access

This section contains information intended for healthcare institutions and professionals (hereinafter "licensed medical specialists") and includes specialized professional information about pharmaceuticals, including prescription medications. This information encompasses details such as drug names, descriptions, usage instructions, potential side effects, contraindications, and other professional information. The information is for informational purposes only and should not be used as a guide for self-diagnosis or treatment. Medication should be used only as directed by a physician, as self-treatment can be harmful to health.

Do you confirm that you have reviewed this restriction on information access and are a healthcare specialist?

No

Дякуємо за звернення!

Ваша форма успішно відправлена. Якщо у вас виникли додаткові питання, будь ласка, заповніть форму на сайті або зателефонуйте нам

Pharmacovigilance

If you have any information about an adverse reaction and/or lack of efficacy of an Arterium Corporation drug, please fill out the form: